45 related articles for article (PubMed ID: 24041831)
1. Thrombotic microangiopathy in a patient with anti-signal recognition particle antibody-positive immune-mediated necrotizing myopathy.
Sakai K; Takahashi M; Ito Y; Yamada S; Ito T; Higuchi Y; Kameda S
Int J Rheum Dis; 2024 Jan; 27(1):e14942. PubMed ID: 37828793
[TBL] [Abstract][Full Text] [Related]
2. Anti-SRP Myopathy with Sensorimotor Polyneuropathy: A Case Report.
Huang LY; Peng YJ; Sung YF
Acta Neurol Taiwan; 2023 Dec; 32(4)():212-217. PubMed ID: 37723914
[TBL] [Abstract][Full Text] [Related]
3. Granulomatous myopathy co-existent immune-mediated necrotizing myopathy: A case report.
Yin C; Yin S; Zheng D; Huang L; Fu Q
Clin Neurol Neurosurg; 2023 Sep; 232():107844. PubMed ID: 37421929
[TBL] [Abstract][Full Text] [Related]
4. Plasma Exchange in Anti-Signal Recognition Particle Myopathy: A Systematic Review and Combined Analysis of Patient Individual Data.
Martínez-Rodríguez P; Escribano-Iglesias M; Crisolino-Pozas ÁP; Cubino-Boveda N; López-Parra M; Marcos M; Chamorro AJ
J Pers Med; 2024 Apr; 14(5):. PubMed ID: 38793043
[TBL] [Abstract][Full Text] [Related]
5. Immune-mediated necrotizing myopathy: antibodies and forecast. A literature review.
Toledo Del Castillo B; Rodriguez Represa FJ; Arias Lotto F; Nieto González JC
An Pediatr (Engl Ed); 2024 Apr; 100(4):293-298. PubMed ID: 38599932
[No Abstract] [Full Text] [Related]
6. Immune-Mediated Necrotizing Myopathy (IMNM): A Story of Antibodies.
Julien S; Challier I; Malleter M; Jouen F; Drouot L; Boyer O
Antibodies (Basel); 2024 Feb; 13(1):. PubMed ID: 38390873
[TBL] [Abstract][Full Text] [Related]
7. Anti-SRP-positive necrotising myopathy concurrent with breast malignancy.
Dandasena T; Ingle V; Singhai A; Saigal S
BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38081733
[TBL] [Abstract][Full Text] [Related]
8. Muscle fiber necroptosis in pathophysiology of idiopathic inflammatory myopathies and its potential as target of novel treatment strategy.
Kamiya M; Kimura N; Umezawa N; Hasegawa H; Yasuda S
Front Immunol; 2023; 14():1191815. PubMed ID: 37483632
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiological Mechanisms and Treatment of Dermatomyositis and Immune Mediated Necrotizing Myopathies: A Focused Review.
Kamperman RG; van der Kooi AJ; de Visser M; Aronica E; Raaphorst J
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457124
[TBL] [Abstract][Full Text] [Related]
10. A Rare Case of Anti-HMGCR and Anti-SRP-Positive Immune-Mediated Necrotizing Myopathy.
Khan N; Kazmi Z
Qatar Med J; 2022; 2022(1):6. PubMed ID: 35261909
[TBL] [Abstract][Full Text] [Related]
11. Cardiac troponin T and autoimmunity in skeletal muscle aging.
Zhang T; Feng X; Dong J; Xu Z; Feng B; Haas KM; Cawthon PM; Beavers KM; Nicklas B; Kritchevsky S
Geroscience; 2022 Aug; 44(4):2025-2045. PubMed ID: 35034279
[TBL] [Abstract][Full Text] [Related]
12. Belimumab for Immune-Mediated Necrotizing Myopathy Associated With Anti-SRP Antibodies: A Case Report and Retrospective Review of Patients Treated With Anti-B-Cell Therapy in a Single Center and Literature.
Cui BB; Tian YR; Ma XY; Yin G; Xie Q
Front Immunol; 2021; 12():777502. PubMed ID: 34925350
[TBL] [Abstract][Full Text] [Related]
13. Noncanonical Functions and Cellular Dynamics of the Mammalian Signal Recognition Particle Components.
Faoro C; Ataide SF
Front Mol Biosci; 2021; 8():679584. PubMed ID: 34113652
[TBL] [Abstract][Full Text] [Related]
14. Potential Pathogenic Role of Anti-Signal Recognition Protein and Anti-3-hydroxy-3-methylglutaryl-CoA Reductase Antibodies in Immune-Mediated Necrotizing Myopathies.
Ladislau L; Arouche-Delaperche L; Allenbach Y; Benveniste O
Curr Rheumatol Rep; 2018 Aug; 20(9):56. PubMed ID: 30074107
[TBL] [Abstract][Full Text] [Related]
15. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.
Srivastava P; Dwivedi S; Misra R
Rheumatol Int; 2016 Jul; 36(7):935-43. PubMed ID: 27193471
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapies for Immune-Mediated Myopathies: A Current Perspective.
Needham M; Mastaglia FL
Neurotherapeutics; 2016 Jan; 13(1):132-46. PubMed ID: 26586486
[TBL] [Abstract][Full Text] [Related]
17. The composition of cellular infiltrates in anti-HMG-CoA reductase-associated myopathy.
Chung T; Christopher-Stine L; Paik JJ; Corse A; Mammen AL
Muscle Nerve; 2015 Aug; 52(2):189-95. PubMed ID: 25737145
[TBL] [Abstract][Full Text] [Related]
18. Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications.
Moran EM; Mastaglia FL
Clin Exp Immunol; 2014 Dec; 178(3):405-15. PubMed ID: 25171057
[TBL] [Abstract][Full Text] [Related]
19. Complement-mediated muscle cell lysis: a possible mechanism of myonecrosis in anti-SRP associated necrotizing myopathy (ASANM).
Rojana-udomsart A; Mitrpant C; Bundell C; Price L; Luo YB; Fabian V; Wilton SD; Hollingsworth P; Mastaglia FL
J Neuroimmunol; 2013 Nov; 264(1-2):65-70. PubMed ID: 24041831
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
